Table 1.
Baseline demographic and clinical profile for participants completing the study compared to those lost to follow-up
| Characteristic | Lost to follow-up (N = 5) | Completed the study (N = 35) |
|---|---|---|
| Age (years)a | 22.8 (1.8) | 32.7 (10.3) |
| Duration (years)b | 13 (6–18) | 18 (7–25) |
| Males (%) | 60 | 43 |
| Frequency of SMBG per weekc | 6 (3–8) | 10 (3–19) |
| HbA1c (%) | 8.9 (2.2) | 9.1 (1.4) |
| HbA1c (mmol/mol) | 76.6 (24.3) | 75.8 (15.4) |
| Sum CIDS score | 87.2 (12.8) | 86.5 (13.4) |
| CIDS scoreb | 68.6 (10.0–78.9) | 54.3 (22.9–74.3) |
| PAID score | 24.4 (5.9) | 27.6 (19.4) |
| DTSQ score | 26.2 (6.8) | 26.1 (6.2) |
CIDS confidence in diabetes self-care scale, DTSQ diabetes treatment satisfaction questionnaire, HbA1c glycosylated hemoglobin, PAID problem areas in diabetes management, SMBG self-monitoring of blood glucose
Results expressed as mean (SD) unless otherwise indicated
a t = 2.1, P = 0.04
bMedian (range) or c median (IQR)